Does FAM-TRASTUZUMAB DERUXTECAN-NXKI Cause Dyspnoea? 235 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Dyspnoea have been filed in association with FAM-TRASTUZUMAB DERUXTECAN-NXKI. This represents 3.1% of all adverse event reports for FAM-TRASTUZUMAB DERUXTECAN-NXKI.
235
Reports of Dyspnoea with FAM-TRASTUZUMAB DERUXTECAN-NXKI
3.1%
of all FAM-TRASTUZUMAB DERUXTECAN-NXKI reports
63
Deaths
101
Hospitalizations
How Dangerous Is Dyspnoea From FAM-TRASTUZUMAB DERUXTECAN-NXKI?
Of the 235 reports, 63 (26.8%) resulted in death, 101 (43.0%) required hospitalization, and 11 (4.7%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FAM-TRASTUZUMAB DERUXTECAN-NXKI. However, 235 reports have been filed with the FAERS database.
What Other Side Effects Does FAM-TRASTUZUMAB DERUXTECAN-NXKI Cause?
Nausea (1,037)
Interstitial lung disease (880)
Disease progression (794)
Death (717)
Fatigue (652)
Off label use (651)
Vomiting (464)
Diarrhoea (463)
Pneumonitis (337)
No adverse event (315)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which FAM-TRASTUZUMAB DERUXTECAN-NXKI Alternatives Have Lower Dyspnoea Risk?
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FAMCICLOVIR
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FAMOTIDINE
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FAMOTIDINE\IBUPROFEN
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FARICIMAB
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FARICIMAB-SVOA